Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medco Settlement Sets “Gold Standard” For PBMs Ahead Of Medicare Rx

Executive Summary

Prosecutors expect that other pharmacy benefit management companies will adopt codes of conduct based on Medco's April 26 settlement with 20 state attorneys general and the U.S. Attorney in Philadelphia
Advertisement

Related Content

Caremark Settlement Reinforces PBM Disclosure, Rx Interchange Standards
P&T Committees Will Be New Focus For Pharma Prosecutors
Caremark May Offer Medicare Rx Plan If Risk Is Minimized, CEO Says
PBMs Will Emerge From “Regulatory Cloud” Soon, Express Scripts Predicts
Medco Prosecution Will Continue Under False Claims Act, Kickback Laws
PBMs Still In Prosecutors’ Sights; Express Scripts Faces Spitzer
Medco Contract With AIG Shows That “Transparency” Pays Off, PBM Says
Medco Settlement Will Influence Medicare Part D Regs, Consultant Says
Medco Pays $29.3 Mil. To 20 States; Buys Chance To Write PBM Rules
Medco Pays $29.3 Mil. To 20 States; Buys Chance To Write PBM Rules
Advertisement
UsernamePublicRestriction

Register

PS043873

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel